#GENE_SYMBOL	ENTREZ_GENE_ID	EXOMISER_GENE_PHENO_SCORE	EXOMISER_GENE_VARIANT_SCORE	EXOMISER_GENE_COMBINED_SCORE	HUMAN_PHENO_SCORE	MOUSE_PHENO_SCORE	FISH_PHENO_SCORE	WALKER_SCORE	PHIVE_ALL_SPECIES_SCORE	OMIM_SCORE	MATCHES_CANDIDATE_GENE	HUMAN_PHENO_EVIDENCE	MOUSE_PHENO_EVIDENCE	FISH_PHENO_EVIDENCE	HUMAN_PPI_EVIDENCE	MOUSE_PPI_EVIDENCE	FISH_PPI_EVIDENCE
PEX1	5189	0.7518	0.9292	0.9552	0.7518	0.2420	0.0000	0.5159	0.7518	1.0000	0	Neonatal adrenoleukodystrophy (ORPHA:44): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Primary adrenal insufficiency (HP:0008207), Neurodegeneration (HP:0002180)-Optic atrophy (HP:0000648), 	Neurodegeneration (HP:0002180)-retinal cone cell degeneration (MP:0008444), 		Proximity to PEX26 associated with Neonatal adrenoleukodystrophy (ORPHA:44): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Primary adrenal insufficiency (HP:0008207), Neurodegeneration (HP:0002180)-Optic atrophy (HP:0000648), 		
DMXL2	23312	0.5035	1.0000	0.7557	0.3677	0.2418	0.0000	0.5035	0.5035	1.0000	0	Polyendocrine-polyneuropathy syndrome (ORPHA:453533): Primary adrenal insufficiency (HP:0008207)-Central hypothyroidism (HP:0011787), 	Abnormality of the cerebral white matter (HP:0002500)-multiple persisting craniopharyngeal ducts (MP:0013968), 		Proximity to ATP6V1E1 associated with Autosomal recessive cutis laxa type 2, classic type (ORPHA:357074): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Seizure (HP:0001250)-Seizure (HP:0001250), 		
ADGRA3	166647	0.5031	0.9973	0.7503	0.0000	0.0000	0.0000	0.5031	0.5031	1.0000	0					Proximity to ROBO1 Abnormality of the cerebral white matter (HP:0002500)-abnormal hippocampal commissure morphology (MP:0008221), 	
TPTE	7179	0.5039	0.9945	0.7470	0.0000	0.0000	0.0000	0.5039	0.5039	1.0000	0				Proximity to SPG21 associated with Autosomal recessive spastic paraplegia type 21 (ORPHA:101001): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Neurodegeneration (HP:0002180)-Frontotemporal cerebral atrophy (HP:0006892), Abnormality of the cerebral white matter (HP:0002500)-Hypoplasia of the corpus callosum (HP:0002079), 		
CSH1	1442	0.5001	0.9842	0.7209	0.0000	0.3574	0.0000	0.5001	0.5001	1.0000	0		Abnormality of the cerebral white matter (HP:0002500)-small pituitary gland (MP:0005361), 		Proximity to LEP associated with Obesity due to congenital leptin deficiency (ORPHA:66628): Primary adrenal insufficiency (HP:0008207)-Pituitary hypothyroidism (HP:0008245), 	Proximity to LEP Primary adrenal insufficiency (HP:0008207)-hypersecretion of corticosterone (MP:0001744), Abnormality of the cerebral white matter (HP:0002500)-abnormal cortical plate morphology (MP:0008439), 	
COL6A6	131873	0.5001	0.9447	0.6425	0.0000	0.0000	0.0000	0.5001	0.5001	1.0000	0				Proximity to COL4A1 associated with Microangiopathy and leukoencephalopathy, pontine, autosomal dominant (OMIM:618564): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Abnormality of the cerebral white matter (HP:0002500)-Hyperintensity of cerebral white matter on MRI (HP:0030890), 	Proximity to COL4A1 Seizure (HP:0001250)-seizures (MP:0002064), Abnormality of the cerebral white matter (HP:0002500)-abnormal brain morphology (MP:0002152), 	
KIF27	55582	0.5021	0.9298	0.6153	0.0000	0.3599	0.0000	0.5021	0.5021	1.0000	0		Abnormality of the cerebral white matter (HP:0002500)-abnormal brain ventricular system morphology (MP:0002200), 		Proximity to GLI3 associated with Pallister-Hall syndrome (ORPHA:672): Seizure (HP:0001250)-Focal emotional seizure with laughing (HP:0010821), Primary adrenal insufficiency (HP:0008207)-Primary adrenal insufficiency (HP:0008207), Abnormality of the cerebral white matter (HP:0002500)-Abnormal corpus callosum morphology (HP:0001273), 	Proximity to GLI3 Neurodegeneration (HP:0002180)-spongiform encephalopathy (MP:0002654), Abnormality of the cerebral white matter (HP:0002500)-absent hippocampal commissure (MP:0008223), 	
VWF	7450	0.5011	0.9222	0.5961	0.0000	0.0000	0.0000	0.5011	0.5011	1.0000	0					Proximity to HSPA5 Abnormality of the cerebral white matter (HP:0002500)-abnormal brain internal capsule morphology (MP:0008128), 	
RIPK3	11035	0.5033	0.9166	0.5895	0.0000	0.2765	0.0000	0.5033	0.5033	1.0000	0		Primary adrenal insufficiency (HP:0008207)-decreased susceptibility to induced pancreatitis (MP:0004155), 		Proximity to NFKB2 associated with Deficiency in anterior pituitary function-variable immunodeficiency syndrome (ORPHA:293978): Seizure (HP:0001250)-Generalized non-motor (absence) seizure (HP:0002121), Primary adrenal insufficiency (HP:0008207)-Adrenocorticotropin deficient adrenal insufficiency (HP:0011735), 	Proximity to NFKB2 Mental deterioration (HP:0001268)-hunched posture (MP:0001505), 	
MRPL45	84311	0.5000	0.9145	0.5763	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to NDN associated with Prader-Willi syndrome (OMIM:176270): Seizure (HP:0001250)-Seizure (HP:0001250), Psychosis (HP:0000709)-Psychosis (HP:0000709), Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 	Proximity to NDN Mental deterioration (HP:0001268)-abnormal spatial learning (MP:0001463), Abnormality of the cerebral white matter (HP:0002500)-abnormal hypothalamus morphology (MP:0000837), 	
MUC4	4585	0.5005	0.9133	0.5749	0.0000	0.0000	0.0000	0.5005	0.5005	1.0000	0				Proximity to SAMD9 associated with MIRAGE syndrome (OMIM:617053): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
FARP2	9855	0.5051	0.8957	0.5468	0.0000	0.0000	0.0000	0.5051	0.5051	1.0000	0					Proximity to PLXNA4 Abnormality of the cerebral white matter (HP:0002500)-abnormal anterior commissure morphology (MP:0008225), 	
KIR2DL1	3802	0.5001	0.8969	0.5366	0.0000	0.0000	0.0000	0.5001	0.5001	1.0000	0				Proximity to TYROBP associated with Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 (OMIM:221770): Mental deterioration (HP:0001268)-Frontal lobe dementia (HP:0000727), Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Leukoencephalopathy (HP:0002352), Abnormality of the cerebral white matter (HP:0002500)-Leukoencephalopathy (HP:0002352), 		
OXER1	165140	0.5011	0.8874	0.5175	0.0000	0.0000	0.0000	0.5011	0.5011	1.0000	0				Proximity to GAL associated with ?Epilepsy, familial temporal lobe, 8 (OMIM:616461): Seizure (HP:0001250)-Focal impaired awareness seizure (HP:0002384), 	Proximity to GAL Mental deterioration (HP:0001268)-abnormal object recognition memory (MP:0001458), Seizure (HP:0001250)-seizures (MP:0002064), Primary adrenal insufficiency (HP:0008207)-abnormal gland physiology (MP:0002164), Abnormality of the cerebral white matter (HP:0002500)-abnormal hippocampus morphology (MP:0000807), 	
MACC1	346389	0.5000	0.8545	0.4395	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to TYROBP associated with Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 (OMIM:221770): Mental deterioration (HP:0001268)-Frontal lobe dementia (HP:0000727), Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Leukoencephalopathy (HP:0002352), Abnormality of the cerebral white matter (HP:0002500)-Leukoencephalopathy (HP:0002352), 		
MCIDAS	345643	0.5000	0.8509	0.4313	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to MCM4 associated with Immunodeficiency 54 (OMIM:609981): Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
NFRKB	4798	0.5003	0.8420	0.4120	0.0000	0.0000	0.0000	0.5003	0.5003	1.0000	0				Proximity to ACTL6B associated with Undetermined early-onset epileptic encephalopathy (ORPHA:442835): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Seizure (HP:0001250)-Status epilepticus (HP:0002133), Neurodegeneration (HP:0002180)-Cerebral atrophy (HP:0002059), Abnormality of the cerebral white matter (HP:0002500)-Abnormal corpus callosum morphology (HP:0001273), 		
LAMA3	3909	0.5050	0.8341	0.4065	0.0000	0.0000	0.0000	0.5050	0.5050	1.0000	0				Proximity to PRNP associated with Cerebral amyloid angiopathy, PRNP-related (OMIM:137440): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Psychosis (HP:0000709)-Psychosis (HP:0000709), Neurodegeneration (HP:0002180)-Cerebellar atrophy (HP:0001272), 	Proximity to PRNP Mental deterioration (HP:0001268)-impaired coordination (MP:0001405), Neurodegeneration (HP:0002180)-neurodegeneration (MP:0002229), Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebral cortex morphology (MP:0000788), 	
LOXHD1	125336	0.5006	0.8315	0.3900	0.0000	0.2305	0.0000	0.5006	0.5006	1.0000	0		Neurodegeneration (HP:0002180)-cochlear hair cell degeneration (MP:0004362), 		Proximity to CDH23 associated with Cushing disease (ORPHA:96253): Psychosis (HP:0000709)-Psychosis (HP:0000709), Primary adrenal insufficiency (HP:0008207)-Adrenal hyperplasia (HP:0008221), 	Proximity to CDH23 Mental deterioration (HP:0001268)-trunk curl (MP:0001512), 	
MAN1B1	11253	0.5369	0.7833	0.3745	0.5369	0.0000	0.0000	0.5002	0.5369	1.0000	0	Autosomal recessive non-syndromic intellectual disability (ORPHA:88616): Seizure (HP:0001250)-Generalized-onset seizure (HP:0002197), Neurodegeneration (HP:0002180)-Cerebral atrophy (HP:0002059), Abnormality of the cerebral white matter (HP:0002500)-Large basal ganglia (HP:0007048), 				Proximity to CANX Mental deterioration (HP:0001268)-abnormal gait (MP:0001406), Abnormality of the cerebral white matter (HP:0002500)-abnormal brain internal capsule morphology (MP:0008128), 	
AHI1	54806	0.5120	0.7929	0.3355	0.4920	0.3841	0.0000	0.5120	0.5120	1.0000	0	Joubert syndrome (ORPHA:475): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Abnormality of the hypothalamus-pituitary axis (HP:0000864), Abnormality of the cerebral white matter (HP:0002500)-Aplasia/Hypoplasia of the corpus callosum (HP:0007370), 	Abnormality of the cerebral white matter (HP:0002500)-decreased brain size (MP:0000774), 			Proximity to HAP1 Neurodegeneration (HP:0002180)-neurodegeneration (MP:0002229), Abnormality of the cerebral white matter (HP:0002500)-abnormal hypothalamus morphology (MP:0000837), 	
NOP14	8602	0.5017	0.7995	0.3252	0.0000	0.0000	0.0000	0.5017	0.5017	1.0000	0				Proximity to RBM28 associated with ?Alopecia, neurologic defects, and endocrinopathy syndrome (OMIM:612079): Mental deterioration (HP:0001268)-Motor deterioration (HP:0002333), Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
NABP1	64859	0.5002	0.8000	0.3226	0.0000	0.0000	0.0000	0.5002	0.5002	1.0000	0				Proximity to NBN associated with Nijmegen breakage syndrome (OMIM:251260): Primary adrenal insufficiency (HP:0008207)-Premature ovarian insufficiency (HP:0008209), Neurodegeneration (HP:0002180)-Neurodegeneration (HP:0002180), 		
CBR4	84869	0.5000	0.8000	0.3222	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to GUSB associated with Mucopolysaccharidosis VII (OMIM:253220): Primary adrenal insufficiency (HP:0008207)-Hepatomegaly (HP:0002240), Neurodegeneration (HP:0002180)-Neurodegeneration (HP:0002180), 	Proximity to GUSB Mental deterioration (HP:0001268)-abnormal gait (MP:0001406), 	
SMG8	55181	0.5009	0.7980	0.3202	0.0000	0.0000	0.0000	0.5009	0.5009	1.0000	0				Proximity to UPF3B associated with X-linked intellectual disability with marfanoid habitus (ORPHA:776): Seizure (HP:0001250)-Seizure (HP:0001250), Psychosis (HP:0000709)-Psychosis (HP:0000709), Primary adrenal insufficiency (HP:0008207)-Macroorchidism (HP:0000053), Abnormality of the cerebral white matter (HP:0002500)-Aplasia/Hypoplasia of the corpus callosum (HP:0007370), 	Proximity to UPF3B Mental deterioration (HP:0001268)-impaired cued conditioning behavior (MP:0009456), 	
DNAH11	8701	0.5018	0.7957	0.3176	0.0000	0.0000	0.0000	0.5018	0.5018	1.0000	0				Proximity to DCTN1 associated with Amyotrophic lateral sclerosis (ORPHA:803): Primary adrenal insufficiency (HP:0008207)-Xerostomia (HP:0000217), Neurodegeneration (HP:0002180)-Neurodegeneration (HP:0002180), 	Proximity to DCTN1 Mental deterioration (HP:0001268)-short stride length (MP:0001407), Neurodegeneration (HP:0002180)-motor neuron degeneration (MP:0000938), 	
URB1	9875	0.5000	0.7968	0.3158	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to MMACHC associated with Methylmalonic aciduria and homocystinuria, cblC type (OMIM:277400): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Cerebral cortical atrophy (HP:0002120), 		
AKAP3	10566	0.5000	0.7894	0.3013	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to PRKAR1A associated with Pigmented nodular adrenocortical disease, primary, 1 (OMIM:610489): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Psychosis (HP:0000709)-Psychosis (HP:0000709), Primary adrenal insufficiency (HP:0008207)-Pigmented micronodular adrenocortical disease (HP:0001580), 		
RBPJL	11317	0.5027	0.7799	0.2889	0.0000	0.0000	0.0000	0.5027	0.5027	1.0000	0				Proximity to TBX19 associated with Congenital isolated ACTH deficiency (ORPHA:199296): Seizure (HP:0001250)-Hypoglycemic seizures (HP:0002173), Primary adrenal insufficiency (HP:0008207)-Adrenocorticotropin deficient adrenal insufficiency (HP:0011735), 	Proximity to TBX19 Primary adrenal insufficiency (HP:0008207)-adrenal gland hypoplasia (MP:0000640), Abnormality of the cerebral white matter (HP:0002500)-decreased corticotroph cell number (MP:0008341), 	
OR2M3	127062	0.5000	0.7631	0.2530	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to ATXN3 associated with Machado-Joseph disease (OMIM:109150): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Neurodegeneration (HP:0002180)-Cerebellar atrophy (HP:0001272), 	Proximity to ATXN3 Mental deterioration (HP:0001268)-impaired coordination (MP:0001405), Neurodegeneration (HP:0002180)-neurodegeneration (MP:0002229), Abnormality of the cerebral white matter (HP:0002500)-abnormal Purkinje cell morphology (MP:0000877), 	
ANKS1A	23294	0.5001	0.7450	0.2232	0.0000	0.0000	0.0000	0.5001	0.5001	1.0000	0				Proximity to ATP13A2 associated with Kufor-Rakeb syndrome (OMIM:606693): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Seizure (HP:0001250)-Seizure (HP:0001250), Psychosis (HP:0000709)-Psychotic episodes (HP:0000725), 	Proximity to ATP13A2 Mental deterioration (HP:0001268)-abnormal spatial learning (MP:0001463), 	
USP40	55230	0.5063	0.7338	0.2165	0.0000	0.0000	0.0000	0.5063	0.5063	1.0000	0				Proximity to PEX6 associated with Neonatal adrenoleukodystrophy (ORPHA:44): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Primary adrenal insufficiency (HP:0008207), Neurodegeneration (HP:0002180)-Optic atrophy (HP:0000648), 		
CNTNAP3B	728577	0.3202	0.9397	0.2093	0.0000	0.3202	0.0000	0.0000	0.3202	1.0000	0		Mental deterioration (HP:0001268)-abnormal motor learning (MP:0002804), 				
ATXN1	6310	0.2532	0.9831	0.1641	0.3829	0.4476	0.0000	0.5064	0.5064	0.5000	0	Spinocerebellar ataxia type 1 (ORPHA:98755): Neurodegeneration (HP:0002180)-Atrophy/Degeneration affecting the brainstem (HP:0007366), 	Mental deterioration (HP:0001268)-abnormal spatial learning (MP:0001463), Neurodegeneration (HP:0002180)-decreased Purkinje cell number (MP:0000880), Abnormality of the cerebral white matter (HP:0002500)-decreased brain weight (MP:0002175), 		Proximity to ATXN2 associated with Spinocerebellar ataxia type 2 (ORPHA:98756): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Neurodegeneration (HP:0002180)-Spinal cord posterior columns myelin loss (HP:0008311), Abnormality of the cerebral white matter (HP:0002500)-Abnormality of the substantia nigra (HP:0045007), 	Proximity to ATXN2 Mental deterioration (HP:0001268)-impaired coordination (MP:0001405), Primary adrenal insufficiency (HP:0008207)-intrahepatic cholestasis (MP:0005415), 	
BAHCC1	57597	0.2896	0.9333	0.1537	0.0000	0.2896	0.0000	0.0000	0.2896	1.0000	0		Mental deterioration (HP:0001268)-abnormal gait (MP:0001406), 				
ASPM	259266	0.5001	0.6880	0.1454	0.4514	0.4814	0.0000	0.5001	0.5001	1.0000	0	Microcephaly 5, primary, autosomal recessive (OMIM:608716): Seizure (HP:0001250)-Seizure (HP:0001250), Abnormality of the cerebral white matter (HP:0002500)-Agenesis of corpus callosum (HP:0001274), 	Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebral hemisphere morphology (MP:0008540), 			Proximity to RND3 Mental deterioration (HP:0001268)-abnormal limb posture (MP:0004263), Seizure (HP:0001250)-convulsive seizures (MP:0000947), 	
SPECC1L	23384	0.3932	0.8042	0.1400	0.3932	0.0000	0.0000	0.0000	0.3932	1.0000	0	Opitz GBBB syndrome, type II (OMIM:145410): Primary adrenal insufficiency (HP:0008207)-Absent gallbladder (HP:0011467), Neurodegeneration (HP:0002180)-Cerebral cortical atrophy (HP:0002120), Abnormality of the cerebral white matter (HP:0002500)-Agenesis of corpus callosum (HP:0001274), 					
IGFN1	91156	0.5040	0.6732	0.1339	0.0000	0.0000	0.0000	0.5040	0.5040	1.0000	0				Proximity to EEF1A2 associated with Undetermined early-onset epileptic encephalopathy (ORPHA:442835): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Seizure (HP:0001250)-Status epilepticus (HP:0002133), Neurodegeneration (HP:0002180)-Cerebral atrophy (HP:0002059), Abnormality of the cerebral white matter (HP:0002500)-Abnormal corpus callosum morphology (HP:0001273), 	Proximity to EEF1A2 Mental deterioration (HP:0001268)-impaired coordination (MP:0001405), Neurodegeneration (HP:0002180)-motor neuron degeneration (MP:0000938), 	
RECQL5	9400	0.5001	0.6732	0.1293	0.0000	0.0000	0.0000	0.5001	0.5001	1.0000	0				Proximity to SMC1A associated with Wiedemann-Steiner syndrome (ORPHA:319182): Mental deterioration (HP:0001268)-Psychomotor deterioration (HP:0002361), Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Growth hormone deficiency (HP:0000824), Abnormality of the cerebral white matter (HP:0002500)-Abnormal corpus callosum morphology (HP:0001273), 		
OTOG	340990	0.5003	0.6635	0.1198	0.0000	0.3426	0.0000	0.5003	0.5003	1.0000	0		Mental deterioration (HP:0001268)-abnormal posture (MP:0001504), 		Proximity to CDH23 associated with Cushing disease (ORPHA:96253): Psychosis (HP:0000709)-Psychosis (HP:0000709), Primary adrenal insufficiency (HP:0008207)-Adrenal hyperplasia (HP:0008221), 	Proximity to CDH23 Mental deterioration (HP:0001268)-trunk curl (MP:0001512), 	
DAPK1	1612	0.5029	0.6550	0.1146	0.0000	0.2896	0.0000	0.5029	0.5029	1.0000	0		Mental deterioration (HP:0001268)-abnormal gait (MP:0001406), 		Proximity to NTN1 associated with Familial congenital mirror movements (ORPHA:238722): Primary adrenal insufficiency (HP:0008207)-Hypogonadotropic hypogonadism (HP:0000044), Abnormality of the cerebral white matter (HP:0002500)-Agenesis of corpus callosum (HP:0001274), 	Proximity to NTN1 Mental deterioration (HP:0001268)-abnormal locomotor coordination (MP:0003312), Abnormality of the cerebral white matter (HP:0002500)-abnormal anterior commissure morphology (MP:0008225), 	
SASH1	23328	0.1977	1.0000	0.1141	0.1977	0.0000	0.0000	0.0000	0.1977	1.0000	0	?Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma (OMIM:618373): Primary adrenal insufficiency (HP:0008207)-Multinodular goiter (HP:0005987), 					
DHX37	57647	0.5013	0.6532	0.1112	0.3197	0.0000	0.0000	0.5013	0.5013	1.0000	0	Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies (OMIM:618731): Seizure (HP:0001250)-Infantile spasms (HP:0012469), 			Proximity to RBM28 associated with ?Alopecia, neurologic defects, and endocrinopathy syndrome (OMIM:612079): Mental deterioration (HP:0001268)-Motor deterioration (HP:0002333), Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
GIGYF2	26058	0.2977	0.8622	0.0932	0.5635	0.5955	0.0000	0.5002	0.5955	0.5000	0	Hereditary late-onset Parkinson disease (ORPHA:411602): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Neurodegeneration (HP:0002180)-Cerebral cortical atrophy (HP:0002120), 	Mental deterioration (HP:0001268)-impaired coordination (MP:0001405), Neurodegeneration (HP:0002180)-neurodegeneration (MP:0002229), 			Proximity to FBXO45 Mental deterioration (HP:0001268)-trunk curl (MP:0001512), Abnormality of the cerebral white matter (HP:0002500)-absent brain internal capsule (MP:0008129), 	
AKAP7	9465	0.5004	0.6223	0.0854	0.0000	0.0000	0.0000	0.5004	0.5004	1.0000	0				Proximity to TBC1D24 associated with Familial infantile myoclonic epilepsy (ORPHA:352582): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Seizure (HP:0001250)-Generalized non-motor (absence) seizure (HP:0002121), 	Proximity to TBC1D24 Seizure (HP:0001250)-tonic-clonic seizures (MP:0003997), 	
KPNA4	3840	0.5016	0.6209	0.0853	0.0000	0.0000	0.0000	0.5016	0.5016	1.0000	0				Proximity to GLI3 associated with Pallister-Hall syndrome (ORPHA:672): Seizure (HP:0001250)-Focal emotional seizure with laughing (HP:0010821), Primary adrenal insufficiency (HP:0008207)-Primary adrenal insufficiency (HP:0008207), Abnormality of the cerebral white matter (HP:0002500)-Abnormal corpus callosum morphology (HP:0001273), 	Proximity to GLI3 Neurodegeneration (HP:0002180)-spongiform encephalopathy (MP:0002654), Abnormality of the cerebral white matter (HP:0002500)-absent hippocampal commissure (MP:0008223), 	
SVIL	6840	0.5001	0.5782	0.0585	0.0000	0.0000	0.0000	0.5001	0.5001	1.0000	0				Proximity to VAPB associated with Amyotrophic lateral sclerosis (ORPHA:803): Primary adrenal insufficiency (HP:0008207)-Xerostomia (HP:0000217), Neurodegeneration (HP:0002180)-Neurodegeneration (HP:0002180), 	Proximity to VAPB Mental deterioration (HP:0001268)-impaired coordination (MP:0001405), Neurodegeneration (HP:0002180)-axon degeneration (MP:0005405), 	
ZDHHC8	29801	0.5000	0.5684	0.0536	0.0000	0.3038	0.0000	0.5000	0.5000	1.0000	0		Mental deterioration (HP:0001268)-decreased exploration in new environment (MP:0001417), 		Proximity to MT-ND1 associated with MELAS (ORPHA:550): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Seizure (HP:0001250)-Focal-onset seizure (HP:0007359), Psychosis (HP:0000709)-Psychotic mentation (HP:0001345), Primary adrenal insufficiency (HP:0008207)-Hypothyroidism (HP:0000821), Neurodegeneration (HP:0002180)-Cerebral cortical atrophy (HP:0002120), Abnormality of the cerebral white matter (HP:0002500)-Aplasia/Hypoplasia of the cerebral white matter (HP:0012429), 		
DISP1	84976	0.2546	0.8158	0.0411	0.4856	0.4191	0.0000	0.5092	0.5092	0.5000	0	Microform holoprosencephaly (ORPHA:280200): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Hypothyroidism (HP:0000821), Abnormality of the cerebral white matter (HP:0002500)-Agenesis of corpus callosum (HP:0001274), 	Abnormality of the cerebral white matter (HP:0002500)-abnormal forebrain morphology (MP:0000783), 		Proximity to ZIC2 associated with Microform holoprosencephaly (ORPHA:280200): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Hypothyroidism (HP:0000821), Abnormality of the cerebral white matter (HP:0002500)-Agenesis of corpus callosum (HP:0001274), 	Proximity to ZIC2 Mental deterioration (HP:0001268)-abnormal spatial working memory (MP:0008428), Abnormality of the cerebral white matter (HP:0002500)-abnormal amygdala morphology (MP:0000818), 	
DISP3	57540	0.5001	0.5365	0.0406	0.0000	0.0000	0.0000	0.5001	0.5001	1.0000	0				Proximity to APOE associated with ?Alzheimer disease, protection against, due to APOE3-Christchurch (OMIM:607822): Mental deterioration (HP:0001268)-Dementia (HP:0000726), Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Cerebral cortical atrophy (HP:0002120), 	Proximity to APOE Mental deterioration (HP:0001268)-abnormal thermal nociception (MP:0002733), Seizure (HP:0001250)-abnormal kindling response (MP:0001499), Primary adrenal insufficiency (HP:0008207)-hypersecretion of corticosterone (MP:0001744), Abnormality of the cerebral white matter (HP:0002500)-hypopituitarism (MP:0003348), 	
GPR179	440435	0.5005	0.5352	0.0403	0.0000	0.0000	0.0000	0.5005	0.5005	1.0000	0				Proximity to MCOLN1 associated with Mucolipidosis IV (OMIM:252650): Mental deterioration (HP:0001268)-Progressive neurologic deterioration (HP:0002344), Primary adrenal insufficiency (HP:0008207)-Hypergastrinemia (HP:0500167), Neurodegeneration (HP:0002180)-Cerebellar atrophy (HP:0001272), Abnormality of the cerebral white matter (HP:0002500)-Dysplastic corpus callosum (HP:0006989), 	Proximity to MCOLN1 Mental deterioration (HP:0001268)-hunched posture (MP:0001505), Abnormality of the cerebral white matter (HP:0002500)-decreased brain size (MP:0000774), 	
KMT2C	58508	0.2501	0.8107	0.0376	0.3748	0.0000	0.0000	0.5002	0.5002	0.5000	0	Kleefstra syndrome 2 (OMIM:617768): Seizure (HP:0001250)-Seizure (HP:0001250), 			Proximity to SRY associated with 46,XY partial gonadal dysgenesis (ORPHA:251510): Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
TRIM24	8805	0.5014	0.5230	0.0365	0.0000	0.2175	0.0000	0.5014	0.5014	1.0000	0		Primary adrenal insufficiency (HP:0008207)-increased hepatocyte proliferation (MP:0003893), 		Proximity to ESR2 associated with ?Ovarian dysgenesis 8 (OMIM:618187): Primary adrenal insufficiency (HP:0008207)-Elevated circulating follicle stimulating hormone level (HP:0008232), 	Proximity to ESR2 Mental deterioration (HP:0001268)-abnormal spatial learning (MP:0001463), Neurodegeneration (HP:0002180)-neuron degeneration (MP:0003224), Abnormality of the cerebral white matter (HP:0002500)-abnormal substantia nigra morphology (MP:0000836), 	
ZFP64	55734	0.5001	0.5186	0.0346	0.0000	0.0000	0.0000	0.5001	0.5001	1.0000	0				Proximity to CUX2 associated with Lennox-Gastaut syndrome (ORPHA:2382): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Seizure (HP:0001250)-Focal-onset seizure (HP:0007359), 	Proximity to CUX2 Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebral cortex morphology (MP:0000788), 	
MUC16	94025	0.5005	0.4991	0.0292	0.0000	0.0000	0.0000	0.5005	0.5005	1.0000	0				Proximity to SAMD9 associated with MIRAGE syndrome (OMIM:617053): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
MUC12	10071	0.5005	0.4939	0.0279	0.0000	0.0000	0.0000	0.5005	0.5005	1.0000	0				Proximity to SAMD9 associated with MIRAGE syndrome (OMIM:617053): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
FLG	2312	0.2500	0.7682	0.0257	0.0000	0.0000	0.0000	0.5001	0.5001	0.5000	0					Proximity to OTX1 Seizure (HP:0001250)-convulsive seizures (MP:0000947), Primary adrenal insufficiency (HP:0008207)-abnormal pituitary secretion (MP:0001746), Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebral cortex morphology (MP:0000788), 	
RAB11FIP5	26056	0.5000	0.4787	0.0243	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to MYO5A associated with Neuroectodermal melanolysosomal disease (ORPHA:33445): Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Subcortical cerebral atrophy (HP:0012157), 	Proximity to MYO5A Mental deterioration (HP:0001268)-abnormal eye blink conditioning behavior (MP:0002807), Seizure (HP:0001250)-clonic seizures (MP:0003996), Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebellum morphology (MP:0000849), 	
PTPN21	11099	0.5004	0.4652	0.0216	0.0000	0.0000	0.0000	0.5004	0.5004	1.0000	0					Proximity to FYN Mental deterioration (HP:0001268)-enhanced behavioral response to alcohol (MP:0009751), Seizure (HP:0001250)-audiogenic seizures (MP:0001496), Abnormality of the cerebral white matter (HP:0002500)-abnormal olfactory bulb morphology (MP:0000819), 	
MYH9	4627	0.2504	0.7468	0.0213	0.1849	0.2633	0.0000	0.5009	0.5009	0.5000	0	MYH9-related disease (ORPHA:182050): Primary adrenal insufficiency (HP:0008207)-Elevated hepatic transaminase (HP:0002910), 	Abnormality of the cerebral white matter (HP:0002500)-abnormal brain vasculature morphology (MP:0004950), 		Proximity to HEPACAM associated with Megalencephalic leukoencephalopathy with subcortical cysts 2A (OMIM:613925): Mental deterioration (HP:0001268)-Progressive neurologic deterioration (HP:0002344), Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Cerebral atrophy (HP:0002059), Abnormality of the cerebral white matter (HP:0002500)-Diffuse white matter abnormalities (HP:0007204), 	Proximity to HEPACAM Abnormality of the cerebral white matter (HP:0002500)-cerebral edema (MP:0011854), 	
CUX2	23316	0.3211	0.6439	0.0173	0.6422	0.4503	0.0000	0.5001	0.6422	0.5000	0	Lennox-Gastaut syndrome (ORPHA:2382): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Seizure (HP:0001250)-Focal-onset seizure (HP:0007359), 	Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebral cortex morphology (MP:0000788), 		Proximity to GBA associated with Gaucher disease, type II (OMIM:230900): Mental deterioration (HP:0001268)-Progressive neurologic deterioration (HP:0002344), Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Hepatomegaly (HP:0002240), Neurodegeneration (HP:0002180)-Cerebral atrophy (HP:0002059), 	Proximity to GBA Abnormality of the cerebral white matter (HP:0002500)-abnormal striatum morphology (MP:0004077), 	Proximity to GBA Neurodegeneration (HP:0002180)-abnormal(ly) present in fewer numbers in organism caudal tuberculum dopaminergic neuron (ZP:0001214), 
ZNF717	100131827	0.0000	0.9984	0.0160	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
DNAH14	127602	0.0000	0.9802	0.0136	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
DYRK2	8445	0.5095	0.4020	0.0134	0.0000	0.0000	0.0000	0.5095	0.5095	1.0000	0				Proximity to EIF2B5 associated with Leukoencephalopathy with vanishing white matter (OMIM:603896): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Premature ovarian insufficiency (HP:0008209), Neurodegeneration (HP:0002180)-Leukoencephalopathy (HP:0002352), Abnormality of the cerebral white matter (HP:0002500)-Leukoencephalopathy (HP:0002352), 	Proximity to EIF2B5 Mental deterioration (HP:0001268)-impaired coordination (MP:0001405), Seizure (HP:0001250)-sporadic seizures (MP:0000951), Abnormality of the cerebral white matter (HP:0002500)-abnormal forebrain morphology (MP:0000783), 	
VCL	7414	0.2515	0.6894	0.0128	0.0000	0.3723	0.0000	0.5031	0.5031	0.5000	0		Abnormality of the cerebral white matter (HP:0002500)-decreased brain size (MP:0000774), 		Proximity to PFN1 associated with Amyotrophic lateral sclerosis (ORPHA:803): Primary adrenal insufficiency (HP:0008207)-Xerostomia (HP:0000217), Neurodegeneration (HP:0002180)-Neurodegeneration (HP:0002180), 		
ZNF281	23528	0.5000	0.4062	0.0126	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to SRY associated with 46,XY partial gonadal dysgenesis (ORPHA:251510): Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
GOLGA6L9	440295	0.0000	0.9615	0.0114	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
PLA2G4C	8605	0.5009	0.3901	0.0110	0.0000	0.0000	0.0000	0.5009	0.5009	1.0000	0				Proximity to GNAS associated with ACTH-independent macronodular adrenal hyperplasia (OMIM:219080): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Psychosis (HP:0000709)-Psychosis (HP:0000709), Primary adrenal insufficiency (HP:0008207)-Macronodular adrenal hyperplasia (HP:0008231), 	Proximity to GNAS Mental deterioration (HP:0001268)-abnormal posture (MP:0001504), Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebellar cortex morphology (MP:0004097), 	
PLEKHG4B	153478	0.5010	0.3892	0.0109	0.0000	0.0000	0.0000	0.5010	0.5010	1.0000	0				Proximity to NOTCH3 associated with Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1 (OMIM:125310): Mental deterioration (HP:0001268)-Subcortical dementia (HP:0007123), Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Leukoencephalopathy (HP:0002352), Abnormality of the cerebral white matter (HP:0002500)-Recurrent subcortical infarcts (HP:0007236), 	Proximity to NOTCH3 Mental deterioration (HP:0001268)-decreased exploration in new environment (MP:0001417), Abnormality of the cerebral white matter (HP:0002500)-abnormal brain morphology (MP:0002152), 	
ITGA6	3655	0.5116	0.3607	0.0094	0.0000	0.3833	0.0000	0.5116	0.5116	1.0000	0		Abnormality of the cerebral white matter (HP:0002500)-abnormal cerebral cortex morphology (MP:0000788), 			Proximity to PMP22 Mental deterioration (HP:0001268)-abnormal gait (MP:0001406), Seizure (HP:0001250)-seizures (MP:0002064), 	
CCDC168	643677	0.0000	0.9372	0.0092	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
PLAT	5327	0.2059	0.7037	0.0091	0.0000	0.4118	0.0000	0.0000	0.4118	0.5000	0		Mental deterioration (HP:0001268)-impaired behavioral response to morphine (MP:0009757), 				
NEDD4L	23327	0.2542	0.6396	0.0084	0.4720	0.3166	0.0000	0.5083	0.5083	0.5000	0	Periventricular nodular heterotopia 7 (OMIM:617201): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Cryptorchidism (HP:0000028), Neurodegeneration (HP:0002180)-Optic atrophy (HP:0000648), Abnormality of the cerebral white matter (HP:0002500)-Hypoplasia of the corpus callosum (HP:0002079), 	Primary adrenal insufficiency (HP:0008207)-increased circulating aldosterone level (MP:0002666), 		Proximity to CHMP2B associated with Behavioral variant of frontotemporal dementia (ORPHA:275864): Mental deterioration (HP:0001268)-Frontotemporal dementia (HP:0002145), Seizure (HP:0001250)-Bilateral tonic-clonic seizure (HP:0002069), Psychosis (HP:0000709)-Psychosis (HP:0000709), Neurodegeneration (HP:0002180)-Frontotemporal cerebral atrophy (HP:0006892), Abnormality of the cerebral white matter (HP:0002500)-Abnormality of the cerebral white matter (HP:0002500), 	Proximity to CHMP2B Abnormality of the cerebral white matter (HP:0002500)-abnormal hippocampus CA1 region morphology (MP:0008263), 	
OBSCN	84033	0.0000	0.9268	0.0084	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
IGHV3-53	-1	0.0000	0.9176	0.0077	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
MUC3A	4584	0.0000	0.9086	0.0071	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
MUC7	4589	0.2502	0.6240	0.0070	0.0000	0.0000	0.0000	0.5005	0.5005	0.5000	0				Proximity to SAMD9 associated with MIRAGE syndrome (OMIM:617053): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Adrenal insufficiency (HP:0000846), 		
RREB1	6239	0.2383	0.6270	0.0063	0.4765	0.0000	0.0000	0.0000	0.4765	0.5000	0	22q11.2 deletion syndrome (ORPHA:567): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Hypothyroidism (HP:0000821), Neurodegeneration (HP:0002180)-Optic atrophy (HP:0000648), 					
ZNF331	55422	0.5000	0.3271	0.0061	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to ADA2 associated with ?Sneddon syndrome (OMIM:182410): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Seizure (HP:0001250)-Seizure (HP:0001250), 		
ROBO3	64221	0.5039	0.3205	0.0060	0.3748	0.3166	0.0000	0.5039	0.5039	1.0000	0	Horizontal gaze palsy with progressive scoliosis (ORPHA:2744): Seizure (HP:0001250)-Seizure (HP:0001250), 	Mental deterioration (HP:0001268)-impaired balance (MP:0001525), 			Proximity to ROBO1 Abnormality of the cerebral white matter (HP:0002500)-abnormal hippocampal commissure morphology (MP:0008221), 	
TRBV7-2	-1	0.0000	0.8908	0.0060	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
AIP	9049	0.2500	0.6011	0.0057	0.2881	0.3832	0.0000	0.5001	0.5001	0.5000	0	Acromegaly (ORPHA:963): Primary adrenal insufficiency (HP:0008207)-Anterior hypopituitarism (HP:0000830), 	Primary adrenal insufficiency (HP:0008207)-adrenal gland hyperplasia (MP:0009078), 			Proximity to NPAS3 Mental deterioration (HP:0001268)-abnormal behavioral response to xenobiotic (MP:0009745), Abnormality of the cerebral white matter (HP:0002500)-abnormal corpus callosum morphology (MP:0000780), 	
FO681492.1	102724488	0.0000	0.8708	0.0050	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
KIAA0232	9778	0.0000	0.8637	0.0047	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
SYNE2	23224	0.2537	0.5319	0.0031	0.0000	0.0000	0.0000	0.5075	0.5075	0.5000	0				Proximity to TMEM67 associated with Joubert syndrome (ORPHA:475): Seizure (HP:0001250)-Seizure (HP:0001250), Primary adrenal insufficiency (HP:0008207)-Abnormality of the hypothalamus-pituitary axis (HP:0000864), Abnormality of the cerebral white matter (HP:0002500)-Aplasia/Hypoplasia of the corpus callosum (HP:0007370), 	Proximity to TMEM67 Abnormality of the cerebral white matter (HP:0002500)-absent anterior commissure (MP:0008227), 	
NBPF14	25832	0.0000	0.8149	0.0030	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
MRPS36	92259	0.0000	0.8000	0.0026	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
POM121C	100101267	0.0000	0.8000	0.0026	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
FCGBP	8857	0.0000	0.7904	0.0024	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
MROH7	374977	0.0000	0.7781	0.0021	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
DDX59	83479	0.5000	0.2117	0.0021	0.3276	0.0000	0.0000	0.5000	0.5000	1.0000	0	Orofaciodigital syndrome type 5 (ORPHA:2919): Abnormality of the cerebral white matter (HP:0002500)-Agenesis of corpus callosum (HP:0001274), 			Proximity to PRKAR1A associated with Pigmented nodular adrenocortical disease, primary, 1 (OMIM:610489): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Psychosis (HP:0000709)-Psychosis (HP:0000709), Primary adrenal insufficiency (HP:0008207)-Pigmented micronodular adrenocortical disease (HP:0001580), 		
LRRFIP1	9208	0.5020	0.1935	0.0018	0.0000	0.0000	0.0000	0.5020	0.5020	1.0000	0				Proximity to TLR3 associated with Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2 (OMIM:613002): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Seizure (HP:0001250)-Seizure (HP:0001250), 	Proximity to TLR3 Mental deterioration (HP:0001268)-abnormal learning/memory/conditioning (MP:0002063), Abnormality of the cerebral white matter (HP:0002500)-abnormal dentate gyrus morphology (MP:0000812), 	
NACAD	23148	0.5003	0.1942	0.0018	0.0000	0.0000	0.0000	0.5003	0.5003	1.0000	0				Proximity to CLN5 associated with Ceroid lipofuscinosis, neuronal, 5 (OMIM:256731): Mental deterioration (HP:0001268)-Motor deterioration (HP:0002333), Seizure (HP:0001250)-Seizure (HP:0001250), Neurodegeneration (HP:0002180)-Increased neuronal autofluorescent lipopigment (HP:0002074), 	Proximity to CLN5 Abnormality of the cerebral white matter (HP:0002500)-abnormal brain morphology (MP:0002152), 	
AHNAK2	113146	0.0000	0.7587	0.0018	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
CUBN	8029	0.5235	0.1199	0.0012	0.5235	0.0000	0.0000	0.5010	0.5235	1.0000	0	Imerslund-Grasbeck syndrome 1 (OMIM:261100): Mental deterioration (HP:0001268)-Dementia (HP:0000726), 			Proximity to LMBRD1 associated with Methylmalonic acidemia with homocystinuria type cblF (ORPHA:79284): Seizure (HP:0001250)-Seizure (HP:0001250), Psychosis (HP:0000709)-Psychosis (HP:0000709), 		
F7	2155	0.5001	0.1434	0.0011	0.1512	0.0000	0.0000	0.5001	0.5001	1.0000	0	Congenital factor VII deficiency (ORPHA:327): Primary adrenal insufficiency (HP:0008207)-Ovarian cyst (HP:0000138), 			Proximity to VPS13C associated with Parkinson disease 23, autosomal recessive, early onset (OMIM:616840): Mental deterioration (HP:0001268)-Mental deterioration (HP:0001268), Neurodegeneration (HP:0002180)-Cerebral cortical atrophy (HP:0002120), 		
FAM189B	10712	0.0000	0.7071	0.0011	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
CEP170B	283638	0.0000	0.7000	0.0010	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
ZNF280A	129025	0.5000	0.0957	0.0007	0.0000	0.0000	0.0000	0.5000	0.5000	1.0000	0				Proximity to GAN associated with Giant axonal neuropathy (ORPHA:643): Primary adrenal insufficiency (HP:0008207)-Abnormality of the pituitary gland (HP:0012503), 	Proximity to GAN Mental deterioration (HP:0001268)-abnormal posture (MP:0001504), Seizure (HP:0001250)-seizures (MP:0002064), 	
PRB3	5544	0.0000	0.6449	0.0006	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
NBPF11	200030	0.0000	0.6252	0.0005	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
CDH17	1015	0.5022	0.0274	0.0004	0.0000	0.0000	0.0000	0.5022	0.5022	1.0000	0				Proximity to PSEN1 associated with Behavioral variant of frontotemporal dementia (ORPHA:275864): Mental deterioration (HP:0001268)-Frontotemporal dementia (HP:0002145), Seizure (HP:0001250)-Bilateral tonic-clonic seizure (HP:0002069), Psychosis (HP:0000709)-Psychosis (HP:0000709), Neurodegeneration (HP:0002180)-Frontotemporal cerebral atrophy (HP:0006892), Abnormality of the cerebral white matter (HP:0002500)-Abnormality of the cerebral white matter (HP:0002500), 	Proximity to PSEN1 Neurodegeneration (HP:0002180)-neuron degeneration (MP:0003224), Abnormality of the cerebral white matter (HP:0002500)-abnormal temporal lobe morphology (MP:0000801), 	
BEND7	222389	0.0000	0.5797	0.0003	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
DNAH3	55567	0.0000	0.5680	0.0003	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
IGHV4-31	-1	0.0000	0.5584	0.0003	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
TTLL8	164714	0.0000	0.4936	0.0002	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
TAS2R20	259295	0.0000	0.4894	0.0002	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
CSMD2	114784	0.0000	0.4512	0.0001	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
LILRB1	10859	0.3626	0.0096	0.0001	0.0000	0.3626	0.0000	0.0000	0.3626	1.0000	0		Abnormality of the cerebral white matter (HP:0002500)-abnormal visual cortex morphology (MP:0000805), 				
AC099489.1	400499	0.0000	0.3995	0.0001	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
EFCAB8	388795	0.0000	0.3982	0.0001	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
ETAA1	54465	0.0000	0.3666	0.0000	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
AC005261.1	57343	0.0000	0.3382	0.0000	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
DRICH1	51233	0.0000	0.2423	0.0000	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
GTF2IRD2B	389524	0.0000	0.1609	0.0000	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
WDR97	340390	0.0000	0.0574	0.0000	0.0000	0.0000	0.0000	0.0000	0.0000	1.0000	0						
